To achieve positive absolute performance and superior long-term capital appreciation, with a focus on forming, building, and supporting world-class life sciences, biopharmaceutical and medical technology companies.
Find out MoreDate | Time | Trade Prc | Volume | Buy/Sell | Value | |
---|---|---|---|---|---|---|
11-Jun-24 | 08:48:55 | 1.41 | 5,000 | Sell* | 7,050 | A Automatic Execution |
11-Jun-24 | 08:48:55 | 1.41 | 970 | Sell* | 1,368 | A Automatic Execution |
11-Jun-24 | 08:11:48 | 1.434477 | 11,195 | Unknown* | 16.06k | O Ordinary |
11-Jun-24 | 08:00:22 | 1.41 | 6,029 | Sell* | 8,501 | UT Uncrossing Trade |